Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

NCT04865419 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Trial terminated based on benefit-risk profile assessment

Conditions

Haematological Malignancies

Interventions

DRUG: AZD0466
DRUG: Voriconazole

Sponsor

AstraZeneca